Cannabis News Box

Groff North America is the first DEA-approved company to grow cannabis for medical research

Groff North America is the first DEA-approved company to grow cannabis for medical research

Bethan Rose Jenkins, Cannabis News Writer/Editorial March 14, 2022

A company based in York County, Pennsylvania, is attracting a surge of media attention… and for all of the right reasons. Reports confirm that Groff North America is the first U.S. company to harvest...

https://unsplash.com/s/photos/white-house

DEA supports White House scheme to simplify research into Schedule I substances like cannabis and psychedelics

Bethan Rose Jenkins, Cannabis News Writer/Editorial December 15, 2021

A White House proposal to ease the process of researching Schedule I drugs, such as cannabis and psychedelics, has gained a seal of approval from the Drug Enforcement Administration (DEA) and National...

https://www.huffpost.com/entry/dea-rescheduling-the-drea_b_11819632

Study: Illegal cannabis seizures have ‘decreased dramatically’ amid rise of state-legalization

Bethan Rose Jenkins, Cannabis News Writer/Editorial October 30, 2021

According to a study conducted by a leading cannabis surveyor for the federal U.S. government, state-level legalization has further dented the Drug Enforcement Administration’s (DEA) opportunities to...

https://www.pinterest.com/ddelllinger/bangladesh/

Body of research indicates that Bangladeshi folk medicine practitioners used Cannabis sativa Linnaeus as traditional phytomedicine

Bethan Rose Jenkins, Cannabis News Writer/Editorial July 26, 2021

Cannabis has long been illegal in Bangladesh, but this didn’t stop local folk medicine practitioners from using the plant in traditional phytomedicine! The ethnomedicinal usage of Cannabis sativa...

https://www.huffpost.com/entry/dea-rescheduling-the-drea_b_11819632

DEA to permit additional research of cannabis, but obstacles remain

Bethan Rose Jenkins, Cannabis News Writer/Editorial June 15, 2021

The road to studying cannabis in the United States has not been without its speed bumps. However, efforts to simplify the process of cannabis research are progressing, mainly due to the Drug Enforcement...

Eight U.S. States support cancer patients in psilocybin legal battle against DEA

Eight U.S. States support cancer patients in psilocybin legal battle against DEA

Bethan Rose Jenkins, Cannabis News Writer/Editorial June 15, 2021

A legal battle that aims to provide end-of-life care patients with legal access to psychedelic substances has begun. Because of this, cancer patients who have previously been turned down the opportunity...

https://www.google.com/search?q=medical+cannabis+research&safe=strict&source=lnms&tbm=isch&sa=X&ved=0ahUKEwiCxqTP4MrjAhXc6XMBHXDLA6YQ_AUIEigC&biw=1280&bih=689#imgrc=A7IbDZTPoWMsEM:

U.S. House chooses to expand medical cannabis research

Bethan Rose Jenkins, Cannabis News Writer/Editorial December 15, 2020

On Wednesday, December 9, the U.S. House of Representatives approved a history-making bill that could essentially open the floodgates for scientific cannabis research opportunities.  Composed of many...

https://betterwyo.org/2019/02/14/wyoming-senate-committee-advances-hemp-cbd-legalization-bill/

Hemp industry players want the DEA to classify hemp byproducts fairly

Bethan Rose Jenkins, Cannabis News Writer/Editorial November 15, 2020

A filing submitted on Monday, November 9 in U.S. District Court in Washington DC, saw the Drug Enforcement Administration (DEA) face pressure in regards to substance clarification. In this particular...

https://www.ecosia.org/images?q=illinois+cannabis#id=BAF0AFDC3A7F093302B4CD311E7C8060B161D46F

Adult-use cannabis sales in Illinois hit another new record in September

Bethan Rose Jenkins, Cannabis News Writer/Editorial October 20, 2020

Illinois' recreational cannabis industry is on a continuous race towards success, with sales of legal weed approaching $68 million in September — almost $4 million more than the total sales recorded...

https://www.huffpost.com/entry/dea-rescheduling-the-drea_b_11819632

Federal court rejects DEA request to drop cannabis rescheduling case

Bethan Rose Jenkins, Cannabis News Writer/Editorial August 31, 2020

The Drug Enforcement Administration (DEA) doesn’t seem to be budging on the reclassification of cannabis; it wants to keep the plant bound by Schedule I of the Controlled Substances Act.  However,...

https://www.huffpost.com/entry/dea-rescheduling-the-drea_b_11819632

DEA releases long-awaited regulations for research cannabis supply expansion

Bethan Rose Jenkins, Cannabis News Writer/Editorial April 20, 2020

A joyous occasion was celebrated by cannabis researchers in the United States last month, when the Drug Enforcement Administration (DEA) published draft rules for the supply expansion of research-grade...

Cannabis companies want to stimulate federal research efforts

Cannabis companies want to stimulate federal research efforts

Bethan Rose Jenkins, Cannabis News Writer/Editorial February 7, 2020

Applications to permit cannabis cultivation for research purposes in the United States has been seriously delayed by the Drug Enforcement Administration (DEA). The Agency began welcoming applicants in...

Load More Stories
Activate Search
Drug Enforcement Administration